228 related items for PubMed ID: 16939990
1. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
[Abstract] [Full Text] [Related]
2. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
3. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[Abstract] [Full Text] [Related]
4. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.
J Investig Allergol Clin Immunol; 2002 Jun; 12(2):107-13. PubMed ID: 12371526
[Abstract] [Full Text] [Related]
5. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
Ohbayashi H, Adachi M.
Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
[Abstract] [Full Text] [Related]
6. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
7. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
[Abstract] [Full Text] [Related]
8. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD, Walters EG.
Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
[Abstract] [Full Text] [Related]
9. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
10. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H, Muir JF, Pieters WR.
Respiration; 2001 Jan; 68(5):517-26. PubMed ID: 11694816
[Abstract] [Full Text] [Related]
11. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
J Int Med Res; 2007 Jan; 35(3):361-73. PubMed ID: 17593865
[Abstract] [Full Text] [Related]
12. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients.
Hauber H, Taha R, Bergeron C, Migounov V, Hamid Q, Olivenstein R.
Can Respir J; 2006 Mar; 13(2):73-8. PubMed ID: 16550263
[Abstract] [Full Text] [Related]
13. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CJ, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005309. PubMed ID: 16235400
[Abstract] [Full Text] [Related]
14. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
Chrousos GP, Ghaly L, Shedden A, Iezzoni DG, Harris AG.
Chest; 2005 Jul 19; 128(1):70-7. PubMed ID: 16002918
[Abstract] [Full Text] [Related]
15. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CK, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005309. PubMed ID: 16625634
[Abstract] [Full Text] [Related]
16. Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma.
Nicolini G, Chetta A, Simonazzi A, Tzani P, Aiello M, Olivieri D.
Allergy Asthma Proc; 2010 Apr 19; 31(5):85-90. PubMed ID: 20929599
[Abstract] [Full Text] [Related]
17. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun 19; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
18. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
Corda L, Gardenghi GG, Modina D, Montemurro LT, Novali M, Tantucci C.
Allergy Asthma Proc; 2011 Jun 19; 32(6):29-34. PubMed ID: 22221427
[Abstract] [Full Text] [Related]
19. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar 19; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
20. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ, Stampone P, O'Connor BJ.
Respir Med; 1998 Jun 19; 92 Suppl A():23-31. PubMed ID: 9850360
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
